As interest in telemedicine grows, many of its proponents and vendors increasingly suggest that it is now time to move to full-scale implementation of telemedicine services in a variety of contexts throughout the world, and question the need for further evidence of its utility and cost-effectiveness. We have reviewed the published literature relating to cost-effectiveness studies in telemedicine and have identified some important weaknesses. Ten recommendations regarding the design of economic evaluations of telemedicine are suggested.
Get full access to this article
View all access options for this article.
References
1.
PeredniaA, AllenA.Telemedicine technology and clinical applications. Journal of the American Medical Association1995; 273: 483–8
2.
HaycoxA, WalleyT.Pharmacoeconomics: evaluating the evaluators. British Journal of Clinical Pharmacology1997; 43: 451–6
3.
NHS Centre for Reviews and Dissemination.Report Number 4.York: University of York, January 1996
4.
BrechtRM, GrayCL, PetersonC, YoungbloodB.The University of Texas Medical Branch-Texas Department of Criminal Justice Telemedicine project: findings from the first year of operation. Telemedicine Journal1996; 2: 25–35
5.
BrunicardiBO.Financial analysis of savings from telemedicine in Ohio's prison system. Telemedicine Journal1998; 4: 49–54
6.
McCueMJ, MazmanianPE, HamptonC. The case of Powhatan Correctional Center/Virginia Department of Corrections and Virginia Commonwealth University/Medical College of Virginia. Telemedicine Journal1997; 3: 11–17
